Entero Therapeutics, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Entero Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • Entero Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -22.8 %, a 87.8% increase year-over-year.
  • Entero Therapeutics, Inc. annual Return On Assets for 2023 was -279 %, a 8.75% decline from 2022.
  • Entero Therapeutics, Inc. annual Return On Assets for 2022 was -256 %, a 38.7% increase from 2021.
  • Entero Therapeutics, Inc. annual Return On Assets for 2021 was -418 %, a 43.1% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -279 -22.4 -8.75% Jan 1, 2023 Dec 31, 2023
2022 -256 +162 +38.7% Jan 1, 2022 Dec 31, 2022
2021 -418 -126 -43.1% Jan 1, 2021 Dec 31, 2021
2020 -292 -128 -77.8% Jan 1, 2020 Dec 31, 2020
2019 -164 -0.62 -0.38% Jan 1, 2019 Dec 31, 2019
2018 -164 +3.6 +2.15% Jan 1, 2018 Dec 31, 2018
2017 -167 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.